ENZO BIOCHEM INC·4

May 31, 4:18 PM ET

Eckert Patricia 4

4 · ENZO BIOCHEM INC · Filed May 31, 2023

Insider Transaction Report

Form 4
Period: 2023-05-26
Eckert Patricia
Chief Financial Officer
Transactions
  • Award

    Stock Option (to acquire Common Stock)

    2023-05-26+25,00025,000 total
    Exercise: $2.29From: 2024-05-26Exp: 2028-05-26Common Stock (25,000 underlying)
Holdings
  • Common Stock, $0.01 Par Value

    (indirect: By 401(k))
    19,400
Footnotes (1)
  • [F1]The Reporting Person was granted 25,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on May 26, 2024.

Documents

1 file
  • 4
    ownership.xmlPrimary